Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Substituted quinoline compounds as S-nitrosoglutathione reductase inhibitors

Substituted quinoline compounds as S-nitrosoglutathione reductase inhibitors

US Patent 9433618 · Granted Sep 6, 2016

Estimated economic value: $1,854,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Antibody-sting agonist conjugates and their use in immunotherapy2025
Identifying security vulnerabilities based on access control lists2025
Quinoline cGAS antagonist compounds2025
Quinoline cGAS antagonist compounds2024
Quinoline cGAS antagonist compounds2024
Quinoline cGAS antagonist compounds2024
Antimycobacterial heterocyclic amides2023
Antibody-sting agonist conjugates and their use in immunotherapy2022
Antibody-STING agonist conjugates and their use in immunotherapy2021
Solid forms of an S-Nitrosoglutathione reductase inhibitor2019
Substituted quinoline compounds as S-nitrosoglutathione reductase inhibitors2018
Substituted quinoline compounds as S-nitrosoglutathione reductase inhibitors2018